Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06390059 |
| Title | EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | NovoCure GmbH |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University Hospital Vall d'Hebron | Barcelona | 08035 | Spain | Details | ||
| University Hospital Foundation Jimenez Diaz | Madrid | 28040 | Spain | Details | ||
| Clara Campal Comprehensive Cancer Center (CIOCC) | Madrid | 28050 | Spain | Details | ||
| Regional University Hospital of Malaga | Málaga | 29010 | Spain | Details | ||
| University Clinic of Navarra - Pamplona | Pamplona | 31008 | Spain | Details |